Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 28, 2016
[ Thu, Apr 28th 2016
] - WOPRAI
[ Thu, Apr 28th 2016
] - WOPRAI
[ Thu, Apr 28th 2016
] - WOPRAI
Wed, April 27, 2016
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
[ Wed, Apr 27th 2016
] - WOPRAI
Tue, April 26, 2016
[ Tue, Apr 26th 2016
] - WOPRAI
Mike Guo Downgraded (SRPT) to Sell and Decreased Target to $4 on, Apr 26th, 2016
Published on 2024-10-25 12:27:03 -
Mike Guo of SunTrust Robinson Humphrey, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Sell and Decreased Target from $14 to $4 on, Apr 26th, 2016.
Mike has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, all agree with Mike's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yun Zhong of "Janney Montgomery Scott" Initiated at Hold on, Wednesday, April 20th, 2016
- Brian Abrahams of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $15 on, Tuesday, January 19th, 2016